Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Essential Medicines for Universal Health Coverage Publisher Pubmed



Wirtz VJ1 ; Hogerzeil HV2 ; Gray AL3 ; Bigdeli M6 ; De Joncheere CP4 ; Ewen MA7 ; Gyansalutterodt M8 ; Jing S9 ; Luiza VL10 ; Mbindyo RM11 ; Moller H12 ; Moucheraud C13 ; Pecoul B14 ; Rago L5 Show All Authors
Authors
  1. Wirtz VJ1
  2. Hogerzeil HV2
  3. Gray AL3
  4. Bigdeli M6
  5. De Joncheere CP4
  6. Ewen MA7
  7. Gyansalutterodt M8
  8. Jing S9
  9. Luiza VL10
  10. Mbindyo RM11
  11. Moller H12
  12. Moucheraud C13
  13. Pecoul B14
  14. Rago L5
  15. Rashidian A15, 16
  16. Rossdegnan D17, 18, 19
  17. Stephens PN20
  18. Teerawattananon Y21
  19. Hoen EFM2
  20. Wagner AK17, 18
  21. Yadav P22
  22. Reich MR23
Show Affiliations
Authors Affiliations
  1. 1. Department of Global Health/Center for Global Health and Development, Boston University School of Public Health, Boston, MA, United States
  2. 2. Global Health Unit, Department of Health Sciences, University Medical Centre Groningen, University of Groningen, Groningen, Netherlands
  3. 3. Division of Pharmacology, Discipline of Pharmaceutical Sciences, University of KwaZulu-Natal, Durban, South Africa
  4. 4. Department of Essential Medicines and Health Products, Geneva, Switzerland
  5. 5. Regulation of Medicines and other Health Technologies, Geneva, Switzerland
  6. 6. World Health Organization, Geneva, Switzerland
  7. 7. Health Action International, Amsterdam, Netherlands
  8. 8. Ministry of Health, Accra, Ghana
  9. 9. Peking Union Medical College School of Public Health, Beijing, China
  10. 10. National School of Public Health Sergio Arouca, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil
  11. 11. World Health Organization, Country Office, Nairobi, Kenya
  12. 12. United Nations Children's Fund, Supply Division, Copenhagen, Denmark
  13. 13. UCLA Fielding School of Public Health, University of California, Los Angeles, CA, United States
  14. 14. Drugs for Neglected Diseases initiative, Geneva, Switzerland
  15. 15. Department of Information, Evidence and Research, Eastern Mediterranean Region, World Health Organization, Cairo, Egypt
  16. 16. School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
  17. 17. Research, Eastern Mediterranean Region, World Health Organization, Cairo, Egypt
  18. 18. Harvard Medical School, Boston, MA, United States
  19. 19. Harvard Pilgrim Health Care Institute, Boston, MA, United States
  20. 20. IMS Health, London, United Kingdom
  21. 21. Health Intervention and Technology Assessment Program (HITAP), Thai Ministry of Public Health Nonthaburi, Thailand
  22. 22. William Davidson Institute at the University of Michigan, Ann Arbor, MI, United States
  23. 23. Harvard T H Chan School of Public Health, Boston, MA, United States

Source: The Lancet Published:2017


Abstract

[No abstract available]
Experts (# of related papers)
Other Related Docs
9. Improving Adverse Drug Event Reporting by Health Care Professionals, Cochrane Database of Systematic Reviews (2017)
12. Antioxidant Supplements and Breast Cancer: A Systematic Review and Meta-Analysis, International Journal of Cancer Management (2018)
20. Providing a Framework for Assessment of the Access to Medicine, DARU# Journal of Pharmaceutical Sciences (2019)
21. Challenges to Achieving Universal Health Coverage Throughout the World: A Systematic Review, Journal of Preventive Medicine and Public Health (2022)